Shares of Nutrien Ltd. (NYSE:NTR – Get Free Report) have earned an average recommendation of “Hold” from the eighteen analysts that are presently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and eleven have given a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $58.95.
NTR has been the subject of several research reports. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $58.00 to $60.00 in a research note on Tuesday, December 3rd. Oppenheimer assumed coverage on shares of Nutrien in a research report on Thursday, December 12th. They set an “outperform” rating and a $60.00 target price for the company. Wells Fargo & Company lowered shares of Nutrien from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $62.00 to $50.00 in a research report on Tuesday, September 24th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $60.00 price objective on shares of Nutrien in a report on Friday, September 20th. Finally, CIBC reissued an “outperformer” rating and set a $55.00 target price (down previously from $60.00) on shares of Nutrien in a report on Tuesday, December 10th.
Get Our Latest Research Report on NTR
Nutrien Stock Up 1.3 %
Nutrien (NYSE:NTR – Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The firm had revenue of $5.35 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the previous year, the company posted $0.35 EPS. Nutrien’s revenue for the quarter was down 5.0% on a year-over-year basis. As a group, equities analysts expect that Nutrien will post 3.5 earnings per share for the current year.
Nutrien Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st will be paid a $0.939 dividend. This represents a $3.76 dividend on an annualized basis and a yield of 8.39%. The ex-dividend date is Tuesday, December 31st. This is a boost from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s payout ratio is currently 144.97%.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. Signaturefd LLC boosted its stake in Nutrien by 4.1% in the second quarter. Signaturefd LLC now owns 7,483 shares of the company’s stock worth $381,000 after buying an additional 293 shares in the last quarter. Rothschild Investment LLC purchased a new stake in shares of Nutrien in the 2nd quarter valued at $72,000. Commonwealth Equity Services LLC grew its holdings in shares of Nutrien by 0.4% during the 2nd quarter. Commonwealth Equity Services LLC now owns 105,085 shares of the company’s stock valued at $5,350,000 after purchasing an additional 422 shares during the last quarter. Cadence Wealth Management LLC grew its holdings in shares of Nutrien by 10.0% during the 2nd quarter. Cadence Wealth Management LLC now owns 10,402 shares of the company’s stock valued at $530,000 after purchasing an additional 946 shares during the last quarter. Finally, Drive Wealth Management LLC purchased a new position in Nutrien in the 2nd quarter worth $633,000. Institutional investors own 63.10% of the company’s stock.
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Articles
- Five stocks we like better than Nutrien
- How to Evaluate a Stock Before Buying
- 3 Stocks Helping to Bring AI to Healthcare
- 3 Healthcare Dividend Stocks to Buy
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- The How and Why of Investing in Gold Stocks
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.